Herbert Y Lin

USPTO Granted Patents = 16 (Patent Applications = 5)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 4.5

ph-index = 5

Forward Citations = 162(Granted Patents)

Company Filing History:

10 out of 2,882

The General Hospital Corporation

patents

6 out of 443

Alnylam Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 2011-2020

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10611820 - Nucleic acids encoding hemojuvelin fusion proteins and uses thereof (2020-04-07),

2. 10273273 - Compositions for regulating iron homeostasis and methods of using same (2019-04-30),

3. 9758567 - Hemojuvelin fusion proteins and uses thereof (2017-09-12),

4. 9708379 - Compositions for regulating iron homeostasis and methods of using same (2017-07-18),

5. 9556251 - Methods and compositions to regulate hepcidin expression (2017-01-31),

6. 9506067 - Compositions and methods for inhibiting expression of the HAMP gene (2016-11-29),

7. 9090895 - Compositions and methods for inhibiting expression of the HAMP gene (2015-07-28),

8. 8895002 - Hemojuvelin fusion proteins and uses thereof (2014-11-25),

9. 8865168 - Methods and compositions to regulate hepcidin expression (2014-10-21),

10. 8791250 - Compositions and methods for inhibiting expression of the HAMP gene (2014-07-29),

11. 8637023 - Hemojuvelin fusion proteins (2014-01-28),

12. 8470799 - Compositions and methods for inhibiting expression of the HAMP gene (2013-06-25),

13. 8293236 - Use of modulators of compounds of TGF-β superfamily to regulate hepcidin-mediated iron metabolism (2012-10-23),

14. 8268799 - Compositions and methods for inhibiting expression of the HAMP gene (2012-09-18),

15. 8163711 - Compositions and methods for inhibiting expression of the HAMP gene (2012-04-24),

Title: The Innovative Contributions of Herbert Y Lin

Introduction

Herbert Y Lin is a prominent inventor based in Watertown, MA, known for his groundbreaking work in the field of biotechnology. With an impressive portfolio of 16 patents, Lin has made significant strides in understanding and harnessing the mechanisms of iron homeostasis, which are critical for various biological processes.

Latest Patents

One of Lin's most notable inventions is the patent for "Nucleic acids encoding hemojuvelin fusion proteins and uses thereof." This invention provides a hemojuvelin (HJV) fusion protein, including a human HJV.Fc protein, as well as polynucleotides and vectors encoding such proteins. Furthermore, it offers methods for treating iron-related disorders by administering an HJV fusion protein to patients in need. Another significant patent is for "Compositions for regulating iron homeostasis and methods of using same," which explores hemojuvelin-IgG Fc domain fusion proteins and their derivatives for regulating iron levels and treating associated diseases.

Career Highlights

Lin's career has been marked by his affiliations with innovative organizations. He has contributed to The General Hospital Corporation and Alnylam Pharmaceuticals, Inc., where he applied his expertise in biotechnology to develop solutions that improve patient health outcomes.

Collaborations

Throughout his career, Lin has collaborated with esteemed colleagues such as Jodie L Babitt and Clifford J Woolf. These collaborations reflect the interdisciplinary approach that has characterized his work, combining insights from various fields to address complex health issues.

Conclusion

In conclusion, Herbert Y Lin is a key figure in the realm of biotechnology and innovation. His patents not only advance scientific knowledge but also hold promise for developing new treatments for iron-related disorders. As he continues to innovate, Lin's contributions will likely pave the way for future discoveries and improvements in medical science.

This text is generated by artificial intelligence and may not be accurate.